Stryker (SYK) EBITDA (2009 - 2026)

Stryker (SYK) has 18 years of EBITDA data on file, last reported at $936.0 million in Q1 2026.

• EBITDA for Q1 2026 came in at $936.0 million, up 11.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 billion (up 40.35% YoY), and the FY2025 annual result was $4.9 billion, up 32.53% from the prior year.
• EBITDA declined to $936.0 million in Q1 2026 per SYK's latest filing, from $1.8 billion in the prior quarter.
• Over five years, EBITDA peaked at $1.8 billion in Q4 2025 and troughed at $447.0 million in Q1 2022.
• A 5-year average of $955.5 million and a median of $936.0 million in 2026 frame the typical range for EBITDA.
• The sharpest annual moves came in 2024 and 2025: EBITDA tumbled 53.78% in 2024, then jumped 210.5% in 2025.
• A 5-year view of EBITDA shows it stood at $814.0 million in 2022, then surged by 54.42% to $1.3 billion in 2023, then tumbled by 53.78% to $581.0 million in 2024, then jumped by 210.5% to $1.8 billion in 2025, then sank by 48.12% to $936.0 million in 2026.
• Business Quant data shows SYK's EBITDA at $936.0 million in Q1 2026, $1.8 billion in Q4 2025, and $1.1 billion in Q3 2025.